《免疫疗法的发展趋势》-Trends in Immunotherapy期刊_医学学科领域_期刊列表

当前位置：首页 >> 期刊征稿 >> 学科领域：医学

《免疫疗法的发展趋势》
Trends in Immunotherapy

试试AI期刊投稿推荐助手？满足不同发表需求

学科领域:医学	出版机构：-
ISSN：2573-5985 (O)	出版周期：半年刊
CN：-	影响因子：-
数据库： CNKI Scopus Google Scholar 等
中科院： -	发表版面：正刊
JCR： -	审稿周期：15-30工作日
征稿主题/栏目：包括但不限于癌症免疫治疗、靶向治疗与肿瘤微环境、免疫失调、化学免疫疗法、抗体、自身免疫障碍的治疗方法、药物免疫疗法的疗效、过敏性疾病与免疫疗法、免疫治疗细胞产品、天然产物的免疫调节作用、疫苗开发与应用、细胞因子应用、伤口愈合。

相关介绍

TI是一本开放获取、同行评审的期刊，涵盖了与所有免疫领域相关的各个学科。期刊的目标受众包括来自学术界、医疗行业和教育界等的科研人员、专业从业者和医学学者。它提供了一个分享学术实践的论坛，以推进科学与医学相结合的免疫疗法。

征稿主题：

包括但不限于癌症免疫治疗、靶向治疗与肿瘤微环境、免疫失调、化学免疫疗法、抗体、自身免疫障碍的治疗方法、药物免疫疗法的疗效、过敏性疾病与免疫疗法、免疫治疗细胞产品、天然产物的免疫调节作用、疫苗开发与应用、细胞因子应用、伤口愈合。

About the Journal

Trends in Immunotherapy (TI) is an open access, peer-reviewed journal encompassing various disciplines related to all immune-based areas. TI has a target audience consisting of scientific researchers, professional practitioners and medical scholars from academia, medical industry, and education, etc. It provides a forum to share scholarly practice to advance the immunotherapy in the combination of science and medicine.

TI publishes original research articles, review articles, editorials, mini-review articles, case reports, commentaries, correspondence articles, database articles, perspective articles, short reports, etc. Preliminary studies, pre-clinical and clinical investigative reports are welcomed.

Co-Editor-in-Chief

Prof. Dr. Fukumi Furukawa

Honorary Director/Super Advisor, Head of Center for Dermatology, Cosmetic Dermatology and Plastic Surgery, Japanese Red Cross Society Takatsuki Hospital, Japan

Emeritus Professor Dermatology, Wakayama Medical University, Japan

Prof. Dr. Zhiling Yu

School of Chinese Medicne at Hong Kong Baptist University, Vice Chairperson of Special Committee of Immunology of TCM of World Federation of Chinese Medicine Societies, Council Member of Hong Kong Society for Immunology,China

The research topics of TI include but are not limited to:

1. Cancer immunotherapy

2. Targeted therapy and tumor microenvironment

3. Immune dysregulation, skin barrier dysfunction

4. Chemoimmunotherapy

5. Antibodies

6. Immunomodulators, inhibitors and intensifiers

7. Therapeutic method for auto-immune disorder

8. Efficacy of drug immunotherapy

9. Allergy disorder and immunotherapy

10. Immunotherapy cell-products

11. Immuno-modulatory effects of natural products